Anterior Cruciate Ligament Repair and Biologic Innovations. Issue 5 (May 2017)

• Record Type: Journal Article
• Authors: Waryasz, Gregory R.; Marcaccio, Stephen; Gil, Joseph A.; Owens, Brett D.; Fadale, Paul D.
• Is Part Of: JBJS reviews. Volume 5:Issue 5(2017)
• Publication Date: 2017-05
• Subjects: Bones -- Surgery -- Periodicals; Joints -- Surgery -- Periodicals; Orthopedics -- Periodicals; Orthopedics; General Surgery; Bone Diseases; Joint Diseases; Bones -- Surgery; Joints -- Surgery; Orthopedics; Periodicals; Electronic journals; Periodicals; 617.47
• DOI: 10.2106/JBJS.RVW.16.00050
• Languages: English
• ISSNs: 2329-9185

Abstract

Abstract : Anterior cruciate ligament (ACL) tears are currently treated with allografts and autografts. Advancements in tissue engineering and biosynthetics are improving ACL repair techniques. ACL repair may offer a viable option for skeletally immature patients. U.S. Food and Drug Administration (FDA)-approved biologic scaffolds are undergoing clinical trials currently and may someday offer an off-the-shelf option for treatment.